Bellicum Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The com…

Biotechnology
US, Houston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Bellicum Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Bellicum Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Bellicum Pharmaceuticals, Inc..

End of BLCM's Analysis
CIK: 1358403 CUSIP: 079481404 ISIN: US0794814048 LEI: - UEI: -
Secondary Listings
BLCM has no secondary listings inside our databases.